Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver disease

Trends in Food Science & Technology - Tập 61 - Trang 141-159 - 2017
Laura Baselga-Escudero1, Vanessa Souza-Mello2, Aïda Pascual-Serrano3, Tamiris Rachid2, Adriana Voci4, Ilaria Demori4, Elena Grasselli4,5
1Grup de Recerca en Nutrició i Salut (GRNS), EURECAT-CTNS, Reus, Spain
2Laboratory of Morphometry, Metabolism, and Cardiovascular Diseases, Biomedical Center, Institute of Biology, State University of Rio de Janeiro, Brazil
3Nutrigenomic Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Tarragona, Spain
4DISTAV, Dipartimento di Scienze della Terra, dell’Ambiente e della Vita, Università di Genova, Genova, Italy
5Istituto Nazionale Biostrutture e Biosistemi, Roma, Italy

Tài liệu tham khảo

Akujobi, 2004, Antibacterial activities and preliminary phytochemical screening of four medical plants, Journal of Applied Sciences, 7, 4328

Aller, 2015, Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease, Nutrición Hospitalaria, 32, 2518

Angulo, 2007, Obesity and nonalcoholic fatty liver disease, Nutrition Reviews, 65, S57, 10.1301/nr.2007.jun.S57-S63

Bahramikia, 2009, Efficacy of different fractions of Anethum graveolens leaves on serum lipoproteins and serum and liver oxidative status in experimentally induced hypercholesterolaemic rat models, The American Journal of Chinese Medicine, 37, 685, 10.1142/S0192415X09007168

De Martino, 2015, Chapter 58-essential oils from mediterranean aromatic plants, The Mediterranean Diet, 649, 10.1016/B978-0-12-407849-9.00058-0

Dhandapani, 2002, Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats, Pharmacological Research, 46, 251, 10.1016/S1043-6618(02)00131-7

Hardy, 2015, Nonalcoholic fatty liver disease: New treatments, Current Opinion in Gastroenterology, 31, 175, 10.1097/MOG.0000000000000175

Ibarra, 2011, Carnosic acid-rich rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and improves cholesterol levels and glycaemia in mice on a high-fat diet, British Journal of Nutrition, 106, 1182, 10.1017/S0007114511001620

Johansson, 2009, Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: A meta-analysis, Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, 10, 564, 10.1111/j.1467-789X.2009.00581.x

Mesbahzadeh, 2015, The effects of different levels of peppermint alcoholic extract on body-weight gain and blood biochemical parameters of adult male Wistar rats, Electronic Physician, 7, 1376

Mohammadian, 2016, Antioxidative and hepatoprotective effects of hydroalcoholic extract of Artemisia absinthium L. in rat, Journal of HerbMed Pharmacology, 5, 29

Nolan, 1994, Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone, The New England Journal of Medicine, 331, 1188, 10.1056/NEJM199411033311803

Paschos, 2009, Non alcoholic fatty liver disease and metabolic syndrome, Hippokratia, 13, 9

Sanyal, 2010, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis, The New England Journal of Medicine, 362, 1675, 10.1056/NEJMoa0907929

Shin, 2014, Hepatoprotective effect of aged black garlic extract in rodents, Toxicological Research, 30, 49, 10.5487/TR.2014.30.1.049

Soriguer, 2003, Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats, The British Journal of Nutrition, 90, 1015, 10.1079/BJN2003993

Tavakol, 2015, Hepatoprotective effect of Matricaria chamomilla.L in paraquat induced rat liver injury, Drug Research, 65, 61

Velasco, 2014, The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease, Current Opinion in Clinical Nutrition and Metabolic Care, 17, 453, 10.1097/MCO.0000000000000071

Wang, 2011, Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice, Hepatology Research, 41, 87, 10.1111/j.1872-034X.2010.00747.x

Zeng, 2014, Pentoxifylline for the treatment of nonalcoholic fatty liver disease: A meta-analysis of randomized double-blind, placebo-controlled studies, European Journal of Gastroenterology & Hepatology, 26, 646, 10.1097/MEG.0000000000000068